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Poly(ADP-ribose)Sindbis virus (SINV), the prototype alphavirus, contains a macro domain in the highly conserved N-terminal
region of nonstructural protein 3 (nsP3). However, the biological role of the macro domain is unclear.
Mutations of amino acids 10 and 24 from asparagine to alanine in the ADP-ribose binding region of the macro
domain impaired SINV replication and viral RNA synthesis particularly in neurons, but did not alter binding
of poly(ADP-ribose). Mutation at position 10 had the greatest effect and caused nsP3 instability in neurons,
decreased SINV-induced death of mature, but not immature neurons, and attenuated virulence in 2 week-
old, but not 5 day-old mice. A compensatory mutation at amino acid 31 in the macro domain of nsP3, as well
as reversion of mutated amino acid 10, occurred during replication of double mutant SINV in vitro and in
vivo. The nsP3 macro domain is important for SINV replication and age-dependent susceptibility to
encephalomyelitis.
© 2009 Elsevier Inc. All rights reserved.Introduction
In humans, alphaviruses can cause encephalitis, arthritis, or rash
(Calisher, 1994; Laine et al., 2004). Sindbis virus (SINV), the prototype
alphavirus, causes encephalomyelitis inmice and is amodel system for
study of the pathogenesis of diseases caused by alphavirus infections.
In the nervous system, SINV infection targets neurons, and neurono-
tropism is determined in part by the glycoproteins E1 and E2 on the
virion surface (Lustig et al.,1988). The outcomeof infectiondepends on
SINV neurovirulence and on host factors, including age and genetic
background (Thach et al., 2000; Johnson et al., 1972). Age-dependent
susceptibility is a characteristic of alphavirus encephalitis and is due to
intrinsic properties of neurons, not differences in the immune
response (Fazakerley et al.,1993; Grifﬁn,1976). Newbornmice develop
fatal disease, while adult mice survive infection. Likewise, undiffer-
entiated neurons replicate SINV to higher titer in vitro and are more
susceptible to SINV-induced cell death than differentiated neurons
(Vernon and Grifﬁn, 2005; Burdeinick-Kerr and Grifﬁn, 2005).
SINV is enveloped and has a single positive-strand RNA genome of
11.7 kb. The 3′-terminal one-third of the genome encodes structural
proteins, and the 5′-terminal two-thirds of the genome encodes
nonstructural proteins (nsPs) as polyproteins (P123, P1234). The
nonstructural polyproteins are processed into four nsPs that form
replication complexes in which the polyproteins and individual nsPs
play different roles in virus replication. The replication complexesll rights reserved.containing polyproteins synthesize negative-strand RNA and after the
polyproteins are cleaved into individual nsPs, synthesize positive-
strand RNA (Strauss and Strauss, 1994). nsP1 has guanine-7-
methyltransferase and guanyltransferase activities and plays a role
in capping viral RNAs (Mi et al., 1989; Scheidel et al., 1987). nsP2 has
protease activity and cleaves nonstructural polyproteins (Ding and
Schlesinger, 1989; Hardy and Strauss, 1989), and also exhibits RNA
helicase and 5′ triphosphatase activities (Gomez et al., 1999; Vasiljeva
et al., 2000). nsP4 is the RNA-dependent RNA polymerase (Kamer and
Argos, 1984).
The function of nsP3 is least understood. nsP3 mutants generated
from random insertion and chemical mutagenesis show reduced
minus strand and subgenomic RNA synthesis (LaStarza et al., 1994b;
De et al., 2003). nsP3 also interacts with cellular proteins, which are
presumed to participate in the formation and/or function of viral
replication complexes (Cristea et al., 2006; Frolova et al., 2006;
Gorchakov et al., 2008). However, data supporting an essential role for
nsP3 is limited and it has little homology with other nsPs of positive-
strand RNA viruses (Ahlquist et al., 1985; Haseloff et al., 1984; LaStarza
et al., 1994a). The C-terminal domain is highly variable even in
alphaviruses and is heavily phosphorylated at serine/threonine (Li et
al., 1990). The phosphorylated C-terminal region is not essential for
SINV replication, but nsP3 phosphorylation may play a host cell-
dependent role in SINV minus strand RNA synthesis (De et al., 2003;
LaStarza et al., 1994a).
Unlike the C-terminus, the N-terminal region of nsP3 is well
conserved among alphaviruses. The N-terminal 150 amino acids of
nsP3 was ﬁrst recognized as a domain of unknown function (X
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identiﬁed as a macro domain based on homology to the nonhistone
region of histone macroH2A (Pehrson and Fried, 1992; Pehrson and
Fuji, 1998). Macro domains are ancient and widely distributed
throughout all eukaryotic organisms, bacteria, and archaea, indicating
a ubiquitous and important basic biological function. Macro domains
are also found in nsPs of several positive-strand RNAviruses, including
hepatitis E virus, rubella virus and coronaviruses, as well as
alphaviruses (Gorbalenya et al., 1991; Koonin et al., 1992; Liang et
al., 2000).
Despite the wide distribution and evolutionary conservation of
macro domains, the physiological role is not known. MacroH2A, the
protein with the best studied macro domain, is enriched in
heterochromatin and is involved in regional chromatin silencing and
cell-type speciﬁc regulation of transcription (Changolkar et al., 2008;Fig. 1. Mutation of the nsP3 macro domain does not affect binding of PAR. Homology mo
Archaeoglobus fulgidus) as a template (A, B). The predicted structure of the nsP3 macro d
overall front and rear view images (A) and close view of mutated amino acids (B) are pres
chosen based on identiﬁcation of conserved residues and homology modeling with the Ar
mutated from asparagine (N) to alanine (A) for SINV single mutant (SM10 and SM24, respect
mutant (DM). (D) PAR binding assay. The nsP3 macro domain WT, SM10, SM24 and DM, an
membrane was incubated with or without PAR, followed by incubation with antibody to PALadurner, 2003; Nusinow et al., 2007; Agelopoulos and Thanos, 2006).
These properties are associated with the nonhistone macro domain
which interacts with histone deacetylases and poly(ADP-ribose)
polymerase (PARP) to inhibit histone acetylation and nucleosome
remodeling and repress initiation of transcription (Chakravarthy et al.,
2005; Agelopoulos and Thanos, 2006). In addition, macro domains of
yeast, severe acute respiratory syndrome (SARS) coronavirus and
hepatitis E virus proteins exhibit ADP-ribose-1″ phosphatase activity
in vitro (Martzen et al., 1999; Saikatendu et al., 2005). This enzymatic
activity is dispensable for coronavirus replication, but appears to play
a role in the pathogenesis of mouse hepatitis virus infection (Eriksson
et al., 2008; Putics et al., 2005). The role of macro domains in other
proteins is less clear (Chakravarthy et al., 2005).
Many macro domains can bind various forms of ADP-ribose, such
as mono ADP-ribose, poly(ADP-ribose) (PAR), poly(A) and the SirT1deling of the SINV nsP3 macro domain using Af1521 (a macro domain protein from
omain (blue) and the published structure of Af1521 (green) are superimposed, and
ented. (C) Mutagenesis of the nsP3 macro domain. Amino acids for mutagenesis were
chaeoglobus fulgidus macro domain. One amino acid at position 10 or 24 in nsP3 was
ively), and amino acids at positions 10 and 24were mutated fromN to A for SINV double
d lysozyme (negative control) were dot-blotted onto nitrocellulose membrane, and the
R for detection.
Fig. 2. SINV replication in neurons is affected by mutations in the nsP3 macro domain.
Undifferentiated CSM14.1 (A), 3 week-differentiated CSM14.1 (B) and BHK21 (C) cells
were infected with SINV WT, SM10, SM24, or DM (MOI=10). Virus released into cell
culture media was assessed by plaque assay. Average data of two independent
experiments are presented. Error bars indicate standard error of the mean. ⁎Pb0.05;
⁎⁎Pb0.01; ⁎⁎⁎Pb0.001; Student's t-test comparing SINV WT and DM.
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2007; Egloff et al., 2006; Karras et al., 2005; Kustatscher et al.,
2005). However, individual eukaryotic and viral protein macro
domains vary in the forms of ADP-ribose bound and in the afﬁnity
of binding (Neuvonen and Ahola, 2009). The macro domain of
macroH2A binds OAADPR, but not PAR (Kustatscher et al., 2005;
Comstock and Denu, 2007). The macro domain of Semliki Forest virus
(SFV) binds PAR well, but monomeric ADP-ribose only poorly
(Neuvonen and Ahola, 2009). The signiﬁcance of these different
interactions remains unknown.
To improve understanding of the function and importance of the
nsP3 macro domain in alphavirus encephalitis, we have generated
mutations in the putative ADP-ribose binding site. We characterized
phenotypes of the mutants and revertants that appeared during
replication. We also assessed the effect of mutations on SINV
replication in neurons, synthesis of viral RNAs, and expression of
viral proteins. Finally, we determined the effect of mutations on SINV
virulence in mice at different maturation stages as well as on
replication in undifferentiated and differentiated neuronal cell lines.
Results
Mutations in the predicted ADP-ribose binding site in the nsP3 macro
domain do not affect PAR binding, but do affect SINV replication
Modeling of nsP3 against a macro domain protein from Archaeo-
globus fulgidus (Fig. 1A) predicted that asparagines at amino acids 10
and 24 of nsP3 are at corresponding positions to the two amino acids
in close contact with ADP-ribose in A. fulgidus (Fig. 1B) (10). These
asparagines were changed to alanines to generate SINV with a double
mutation (SINV DM) or with single mutations at amino acid 10 (SINV
SM10) or 24 (SINV SM24) (Fig. 1C). To assess the effect of these
mutations on PAR binding, his-tagged WT and mutant proteins were
tested for interaction with PAR at different concentrations (Fig. 1D).
The mutations had no effect on binding of PAR.
To assess the potential importance of the amino acids at these
positions for SINV replication, undifferentiated (Fig. 2A) and differ-
entiated (Fig. 2B) CSM14.1 cells were infected with SINV WT, SM10,
SM24, or DM. In differentiated CSM14.1 cells, the replication of SINV
SM10 and DM was impaired at early times after infection (Pb0.01
before 24 h). After 24 h, replication of SINV WT plateaued, while
replication of SINV SM10 and DM continued to increase to approxi-
mately the same level as SINV WT. Replication of SINV SM24 was less
impaired, suggesting that the amino acid at position 10 of nsP3 ismore
important for SINV replication in neurons than the amino acid at
position 24. The results in undifferentiated CSM14.1 cells were similar.
In BHK21 cells, however, replication of SINV WT and DM was not
different (Fig. 2C), suggesting that the effect of mutations on SINV
replication is greatest in neurons.
Revertants arise during growth of nsP3 macro domain mutants
in neurons
SINV DM grown in BHK21 cells showed a small plaque phenotype
compared to the large plaques produced by SINVWT (Fig. 3A). Viruses
produced by SINV WT-infected differentiated CSM14.1 cells also
formed large plaques (average diameter of 3 mm). In contrast, viruses
produced by SINV DM-infected differentiated (Fig. 3A) and undiffer-
entiated (data not shown) CSM14.1 cells were a mixture of small
plaques (average diameter of 1.5mm) and a few large plaques (Fig. 3A,
arrow). To determine whether these large plaques were revertants,
plaques from SINV DM grown in undifferentiated or differentiated
CSM14.1 cells, or BHK21 cells were isolated and sequenced. In BHK21
cells, all plaques were original SINV DM with no reversion. In
undifferentiated and differentiated CSM14.1 cells, however, small
plaque viruses retained the original mutations, while large plaqueviruses had reverted alanine (GCT) at amino acid 10 of nsP3 to
threonine (ACT) or aspartate (GAT) (Fig. 3B). These reversions
required only a single nucleotide change and were detected as early
as 8 h after infection of both undifferentiated and differentiated
CSM14.1 cells. SINV DM grown in CSM14.1 cells was also sequenced
directly without plaque isolation (Fig. 3C) and showed co-existence of
the original SINV DM and variants with reversions at amino acid 10.
No reversion was detected at amino acid 24, and SINV SM24 formed
large plaques (data not shown).
Fig. 3. Reversions occur in the nsP3macro domain of SINV DMduring SINV replication. (A) The effect of mutations on plaque phenotype. P0 stocks of SINVWTand DMwere produced
in BHK21 cells, and the plaque phenotype observed (2 pictures on the left). 3 week-differentiated CSM14.1 (dCSM14.1) cells were infected with SINV WT or SINV DM, and viruses
released into culture media were collected at 8 h post-infection. Plaque assay was performed in BHK21 cells to observe plaque phenotype (2 pictures on the right). (B) Analysis of
plaque phenotype and reversions. Plaques from (A) were isolated, grown in BHK21 cells, and sequenced. (C) Assessment of reversions in SINV DM-infected CSM14.1 cells and the
brains of CD-1 mice. P0 stock of SINV DM produced in BHK cells (left), virus released from SINV DM-infected differentiated CSM14.1 cells at 48 h post-infection (middle), and virus
collected from the brains of SINV DM-infected 5 day-old CD-1 mice at 1 day post-infection (right) were sequenced. Electropherogram at amino acids 10, 24, and 31 of nsP3 is shown.
(D) Alignment of SINV nsP3 amino acids 30–33 with other macro domain containing proteins. SFV, Semliki Forest virus; MidV, Middleburg virus; VEEV, Venezuelan equine
encephalomyelitis virus; HEV, hepatitis E virus; RubV, rubella virus; SARS-CoV, severe acute respiratory syndrome coronavirus; GI|3395780, histone macroH2A1.1 from Gallus gallus;
GI|2225961, Mycobacterium tuberculosis; GI|1787283, Escherichia coli; GI|2649040, Archaeoglobus fulgidus; GI|3873699, Caenorhabditis elegans; MSV225, Melanoplus sanguinipes
entomopoxvirus. (E) Homology modeling of the SINV nsP3 macro domain using Af1521 (a macro domain protein from Archaeoglobus fulgidus) as a template. The predicted structure
of the nsP3 macro domain (blue) and the published structure of Af1521 (green) are superimposed, and close view image of nsP3 amino acids 10, 24, and 31 is presented.
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mutation was detected at amino acid 31. A change from glutamate
(GAA) (31E) to glycine (GGA) (31G) was present in plaques from SINV
DM without the reversion at amino acid 10 (Fig. 3B). This second-site
mutation was detected as early as 8 h after infection of CSM14.1 cells
and represented more than 50% of the total virus population (Fig. 3C).
However, this change at amino acid 31 did not increase the plaque size
(Fig. 3B). Although most alphaviruses contain glutamate or aspartate
at the position corresponding to nsP3 31E, most other macro domain
proteins contain glycine (Fig. 3D). When Cα and side chain positions
of nsP3 31E are compared to those of corresponding residues in the
Af1521 macro domain protein from A. fulgidus (Karras et al., 2005),
31E has a bulky side chain that the template glycine residue does not
have, and Cα positions of 31E and nearby residues (30G and 32G) are
not similar to those of corresponding residues in the template (Fig.
3E). In contrast, Cα and side chain positions of nsP3 amino acids 10Nand 24N are highly similar to those of corresponding residues in
Af1521.
Mutations in the nsP3 macro domain affect formation of SINV replication
complexes
To understand how mutations in the nsP3 macro domain affect
SINV replication, we examined the levels of nsPs that form SINV
replication complexes by immunoblotting (Fig. 4). In undifferentiated
(Fig. 4A) and differentiated (Fig. 4B) CSM14.1 cells infected with SINV
DM or SM10, less nsP3 was present at all times examined. In
differentiated CSM cells, levels of nsP2 were also slightly lower,
although nsP2 itself is not mutated. SINV SM24 showed minimal
defects in the level of nsPs consistent with the less pronounced defects
in viral replication. To examine the synthesis and stability of nsPs,
differentiated CSM14.1 cells were labeled with tran35S at 20 h post-
Fig. 4. SINV replication complexes are diminished by mutations in the nsP3 macro domain. The effect of mutations on nsP expression in undifferentiated (A) and 3 week-
differentiated (B) CSM14.1 cells. Cells were infected with SINVWT, SM10, SM24, or DM (MOI=10), or mock infected. Cell lysates were analyzed by immunoblotting using antibodies
to nsP2, nsP3 and actin. (C) The effect of mutations on the stability of nonstructural and structural proteins in CSM14.1 cells. 3 week-differentiated CSM14.1 cells were infected with
SINV WT or DM (MOI=10), or mock infected. At 20 h after infection, newly synthesized proteins were labeled with tran35S for 2 h and chased for 120 min. Cell lysates were
incubated with antibody to nsP3, nsP2, or structural proteins, and then incubated with protein A/G. Immunoprecipitated proteins were separated by PAGE and visualized by
autoradiography. (D) The effect of mutations on the stability of nsP3 in BHK21 cells. Cells were infected with SINV WT or DM (MOI=10), or mock infected. At 6 h after infection,
newly synthesized proteins were labeled with tran35S for 1 h and chased for 90 min followed by immunoprecipitation. (E) The effect of mutations on structural proteins in CSM14.1
cells. 3 week-differentiated CSM14.1 cells were examined for the expression of structural proteins by immunoblotting using antibody to structural proteins.
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and nsP23 were analyzed by immunoprecipitation (Fig. 4C). Similar
amounts of nsP3were synthesized in SINVWT- and DM-infected cells,
but nsP3was rapidly degraded in SINV DM-infected cells. Instability of
mutant nsP3 was not a result of proteasome-mediated degradation
because treatment with a proteasome inhibitor MG132 decreased,
rather than increased, the amount of detectable nsP3 (data not
shown). Furthermore, mutations in the nsP3 macro domain did not
affect nsP3 stability in BHK21 cells (Fig. 4D), indicating that the
folding of mutant nsP3 is intact. The synthesis and stability of nsP2
and nsP23 were not signiﬁcantly affected, suggesting that the
mutations did not affect cleavage of P23 (Fig. 4C).
The effect of mutations in the nsP3 macro domain on the synthesis
and stability of structural proteins (E1, E2, and capsid) was also
assessed in differentiated CSM14.1 cells (Fig. 4E). Lower amounts of
both capsid and E1/E2 were present at 24 h after infection with SINV
DM, but comparable amounts of structural proteins were detected by
48 h. In general, the differences in the amounts of structural proteins
between SINV DM and WT were less apparent than the differences in
the amounts of nonstructural proteins, suggesting that the impair-
ment in the replication of SINV DM results from defects in nsPs. In
addition, the stability of the structural proteins was not affected
(Fig. 4C).
Mutations in the nsP3 macro domain affect the synthesis of SINV RNAs
To understand which step of virus replication is affected by
mutations in the nsP3 macro domain, we compared the synthesis of
viral genomic and subgenomic RNAs as well as plus and minus strand
RNAs (Fig. 5). In differentiated CSM14.1 cells infected with SINVWTor
DM, newly synthesized viral RNAs were labeled with 3H-uridine for
2 h, and genomic and subgenomic RNAs were analyzed on an agarose
gel. Initial RNA synthesis was similar between SINV WT and DM, butthe later ampliﬁcation of RNA synthesis observed in SINV WT
infection did not occur in SINV DM infection (Fig. 5A). The ratios of
genomic to subgenomic RNAs were comparable, and similar to those
observed in previous studies of SINV in differentiated CSM14.1 cells
(Burdeinick-Kerr and Grifﬁn, 2005).
To compare the synthesis of plus and minus strand viral RNAs,
RNAs were puriﬁed from differentiated CSM14.1 cells infected with
SINV WT or DM, and real time RT-PCR was performed using primers
speciﬁcally recognizing plus or minus strand SINV RNA. Synthesis of
both plus (Fig. 5B) and minus (Fig. 5C) strand RNAs was affected by
mutations in the nsP3macro domain at 16, 24, and 30 h post-infection.
Mutations in the nsP3 macro domain reduce SINV-induced death of
mature neurons
Next, we assessed the effect of mutations on SINV-induced
neuronal death. In undifferentiated CSM14.1 cells, no differences in
SINV-induced death were observed between SINV WT and mutants
(Fig. 6A). In differentiated CSM14.1 cells, however, SINV SM10 and DM
caused less death than SINV WT (Pb0.01, 3 days after infection;
Pb0.05, 4 days after infection) (Fig. 6B). Survival of SINV SM24-
infected neurons was modestly improved from that of SINV WT-
infected neurons.
Mutations in the nsP3 macro domain reduce SINV virulence in mice
To assess the importance of the nsP3 macro domain for induction
of encephalomyelitis in vivo, mice were infected with SINV WT or
mutants, and morbidity, mortality and virus replication in brain were
assessed (Fig. 7). Because mutations in the nsP3 macro domain
affected SINV-induced neuronal death only in differentiated neurons
(Fig. 6), we explored the possibility that the effect of mutations on
SINV virulence in mice also depends on age. Two week-old or 5 day-
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infected with PBS. In 5 day-old mice, SINV WT infection resulted in
severe paralysis and death 1.5 days earlier than SINV DM infection
(median survival: WT, 4 days; DM, 5.5 days; Pb0.0001) (Figs. 7A and
C). However, survival curves for WT- and DM-infected mice were not
signiﬁcantly different (P=0.2059, Log-rank test), and all of the mice
infected with WTor mutant viruses died by day 6 after infection. Viral
replication in brain was not different between SINV WT and mutants
(Fig. 7E). In contrast, in 2 week-old mice, SINV WT infection caused
90% mortality, while DM-infected mice remained well (Pb0.0001,
Log-rank test) (Figs. 7B and D). SINV SM10 and SM24 were less
attenuated than SINV DM with 40% mortality (P=0.0228, SM10;
P=0.0170, SM24). SINV WT, and all mutants replicated to high titers
in the brains of 2 week-old mice, but only mutated viruses showed
evidence of clearance 7 days after infection (Fig. 7F).Fig. 5. SINV RNA synthesis is affected by mutations in the nsP3 macro domain. (A) The
effect of mutations on the synthesis of viral genomic and subgenomic RNAs. 3 week-
differentiated CSM14.1 cells were infected with SINVWTor SINV DM, or mock infected.
Cells were treated with Dactinomycin to inhibit cellular RNA synthesis, and newly
synthesized RNAs were labeled with 3H-uridine for 2 h. Puriﬁed RNAs were separated
by agarose gel electrophoresis and visualized by ﬂuorography. (B, C) The effect of
mutations on the synthesis of viral plus (B) and minus (C) strand RNAs. 3 week-
differentiated CSM14.1 cells were infected with SINV WT or SINV DM (MOI=10), or
mock infected. RNAs were puriﬁed from cells, and SINV plus or minus strand RNA was
quantitated by real time RT-PCR. Representative data from two independent experi-
ments are presented. No viral RNA was detected in mock infected cells. Error bars
indicate SEM. ⁎Pb0.05; ⁎⁎Pb0.01; ⁎⁎⁎Pb0.001 (Student's t-test comparing SINV WT
and DM); AU, artiﬁcial unit.
Fig. 6. SINV virulence is affected by mutations in the nsP3 macro domain in mature
neurons. The effect of mutations on SINV virulence in undifferentiated (A) and 3 week-
differentiated (B) CSM14.1 cells. Cells were infected with SINV WT, SINV SM10, SINV
SM24, or SINV DM (MOI=10), or mock infected. Live cells were counted at indicated
days post-infection by trypan blue exclusion assay, and percentage of D0 cells was
calculated. Representative data from 3 independent experiments are presented. In each
experiment, triplicate samples were assessed. Error bars indicate SEM. ⁎Pb0.05;
⁎⁎Pb0.01; ⁎⁎⁎Pb0.001; Student's t-test comparing SINV WT and mutants.Virus produced from the brains of SINV-DM-infected mice was
sequenced and the same reversions at nsP3 amino acids 10 and 31 that
occurred during replication in CSM14.1 cells were detected (Figs. 3B
and C).
Discussion
While the roles of nsP1, nsP2, and nsP4 are well characterized in
SINV replication, the function of nsP3 has been elusive. Previous
studies using SINV variants generated by random insertion or
chemical mutagenesis of nsP3 have reported small reductions in
virus replication and in minus strand or subgenomic RNA synthesis,
but have not focused on themacro domain and have not examined the
in vivo effects of these mutations (De et al., 2003; LaStarza et al.,
1994a,1994b). In this studywe targeted the ADP-ribose binding site in
the macro domain for mutational analysis and showed that the nsP3
macro domain plays an important role in SINV replication although
the mutations did not affect PAR binding. Mutations at nsP3 amino
acids 10 and 24 in the macro domain impaired virus replication and
viral RNA ampliﬁcation, and caused nsP3 instability in neurons. The
greatest effects were detected when amino acid 10 was mutated.
Mutated viruses formed small plaques in BHK21 cells, and virus
variants with a reversion at amino acid 10 or with a second-site
mutation at amino acid 31, also in the macro domain, were rapidly
selected during replication of SINV in cultured neurons and mouse
brains. This study also showed that the mutations in the nsP3 macro
domain impaired virulence for 2 week-old mice and mature cultured
neurons.
Previous studies support a role for the macro domain in SINV
replication. SINV mutants generated by random insertion of linker
Fig. 7. SINV virulence is affected by mutations in the nsP3 macro domain in 2 week-old mice. The effect of mutations on the survival of 5 day-old (A) or 2 week-old (B) CD-1 mice.
Groups of 10 mice were infected with SINV WT, SM10, SM24 or DM (intracerebral injection of 1000 PFU virus), or mock infected with PBS, and monitored daily for survival. Percent
survival was plotted using Kaplan–Meyer analysis and Log-rank test was used for statistics. (C, D) The effect of mutations on the clinical signs of 5 day-old (C) or 2 week-old (D) CD-1
mice. Mice were infected as in (A,B) andmonitored daily for signs of illness. Disease was scored as: 0, no signs of illness; 1, weakness; 2, moderate paralysis in one hindlimb; 3, severe
paralysis in both hind limbs; 4, death. (E,F) The effect of mutations on viral replication in the brains of 5 day-old (E) or 2 week-old (F) CD-1 mice. Mice were infected with SINVWT,
SM10, SM24 or DM and brains collected from 3 mice in each group were homogenized and assayed for PFU using BHK21 cells. Error bars indicate SEM. ⁎Pb0.05; ⁎⁎Pb0.01;
⁎⁎⁎Pb0.001; Student's t-test comparing SINV WT and mutants.
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phenotypes, a decrease in plaque formation, and a defect in RNA
synthesis (LaStarza et al., 1994b). The mutation present in SINV
mutant ts138 (alanine to glycine at residue 68 of nsP3) is associated
with decreased C-terminal nsP3 phosphorylation and decreased
minus strand synthesis (De et al., 2003).
The importance of the nsP3 macro domain is underscored by
reversions that occurred during SINV DM replication in cultured
neurons or the brains of infected mice. Virus variants with a reversion
at nsP3 amino acid 10 to threonine or aspartate (the amino acid
present inmanymacro domains at this position; Neuvonen and Ahola,
2009) emerged shortly after infection, indicating selective pressure.
Furthermore, viruses with a second-site change at nsP3 amino acid 31
(glutamate to glycine) were selected and thus became more
homologous in amino acid sequence and structure to other macro
domains, in which this is a highly conserved amino acid (Neuvonen
and Ahola, 2009; Till and Ladurner, 2009). Viruses with reversions at
amino acid 10 of nsP3 did not have the change at amino acid 31, and
the population of viruses with amino acid 10 reversion increased asthe infection progressed, while the population of viruses with amino
acid 31 reversion decreased (data not shown), suggesting that virus
variants with these amino acid changes are different populations or
are selected at different times after infection. The reciprocal relation-
ship between these amino acid reversions suggests cooperativity and
that a change at residue 31 is not required once the mutation at amino
acid 10 is reverted.
Several positive-strand RNA viruses have conserved macro
domains in their nonstructural proteins, suggesting an evolutionarily
preserved role (Koonin et al., 1992; Gorbalenya et al., 1991). Viral
macro domains are often closely associated with papain-like protease
domains, but no functional link between the macro domain and
protease activity has been reported (Liang et al., 2000; Putics et al.,
2005; Gorbalenya et al., 1991). Some macro domains can hydrolyze
ADP-ribose-1″ phosphate (ADPR-1″P), a product of tRNA splicing, to
yield ADP-ribose. ADPR-1″P phosphatase activity is detected in the
macro domain of hepatitis E virus and coronaviruses (Neuvonen and
Ahola, 2009; Saikatendu et al., 2005), but this enzymatic activity is
dispensable for replication of human coronavirus 229E in vitro (Putics
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enzymatic activity in the coronavirus mouse hepatitis virus A59
results in altered liver pathology in infected mice associated with
decreased induction of IL-6, decreased hepatic necrosis and improved
virus clearance, but little change in peak virus replication.
The macro domains of alphaviruses have little ADPR-1″P phos-
phatase activity. Residue 24 of SINV nsP3 is in the APPR-1″P catalytic
site, and mutation of this site in SFV, along with amino acid 21,
eliminates the small amount of enzymatic activity present in the WT
protein (Neuvonen and Ahola, 2009). SINV SM24 was least impaired
of the mutated SINVs studied, suggesting that the ADPR-1″P
phosphatase activity of nsP3 is not crucial for SINV replication. In
differentiated neurons, SM24 nsP3 was stable, virus replication and
induction of neuronal death were similar to that observed with WT
virus, and revertants were not detected during replication. However,
in 2 week-old mice virulence was attenuated and clearance was
facilitated compared to WT virus, suggesting a potential role in the
pathogenesis of encephalitis.
Many viral macro domains have the ability to interact with ADP-
ribose in some form. The ability of macro domains to bind
monomeric ADP-ribose appears unrelated to the ability to bind
PAR. The macro domain of SFV binds PAR well, but does not
efﬁciently bind monomeric ADP-ribose (Neuvonen and Ahola, 2009).
Likewise, mutations at nsP3 amino acids 10 and 31 in the SFV macro
domain that affect coronavirus binding of monomeric ADP-ribose
(Karras et al., 2005) did not affect binding of PAR (Neuvonen and
Ahola, 2009). Our studies conﬁrm the lack of effect of mutation at
residues 10 and 24 for binding PAR and suggest that additional macro
domain residues are important for this binding. Residues 10 and 24
may be involved in binding another NAD metabolite that has not yet
been examined.
The signiﬁcance of the interaction between PAR and the nsP3
macro domain is unclear. It is possible that some cellular proteins
modiﬁed with PAR are recruited by nsP3 into replication complexes.
However, there is no evidence that a deﬁciency in PAR binding is
important for the phenotypes of themutants we have studied because
all retained the ability to bind PAR.
In vivo studies of nsP3 macro domain mutants are few. Studies of
SFV have shown that mutation of the opal termination codon between
nsP3 and nsP4 to encode arginine increases neurovirulence (Tuittila
and Hinkkanen, 2003; Tuittila et al., 2000). In addition, mutations in
the macro domain at nsP3 amino acid 11 (valine to isoleucine), 48
(alanine to glutamate) and 70 (glycine to alanine) collectively
contribute to increased neurovirulence, but the mechanisms are not
known (Tuittila and Hinkkanen, 2003). We have shown that
mutations in the nsP3 macro domain signiﬁcantly reduced SINV
virulence in 2 week-old mice and impaired the ability of the virus to
induce death in mature neurons. Although replication of SINVWTand
mutants was similar in mice as indicated by titers at 24 h after
infection, the mutations facilitated virus clearance from the nervous
system, a process dependent on the responses of infected cells to
immune effectors such as interferon-γ and antibody (Burdeinick-Kerr
and Grifﬁn, 2005; Levine et al., 1991). A similar effect on virus
clearancewas observed in the studies of MHV A59with a single amino
acid change in the macro domain (Eriksson et al., 2008). These data
further suggest that nsP3 interaction with host factors is affected by
the macro domain amino acid sequence.
Materials and methods
Cell culture
The rat neuronal CSM14.1 cell line was derived from nigral-
striatal neurons immortalized with a temperature-sensitive simian
virus 40 T antigen and was a gift from Dale E. Bredesen (Buck
Institute for Age Research) (Durand et al., 1990; Zhong et al., 1993).CSM14.1 cells were grown at the permissive temperature (31 °C) in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% heat-inactivated fetal bovine serum (FBS), L-glutamine (2 mM),
penicillin (100 U/ml), and streptomycin (100 μg/ml) (Gibco BRL) in
a 5% CO2 incubator. For differentiation, CSM14.1 cells were grown
under permissive conditions until they were 95% conﬂuent and then
switched to the restrictive temperature (39 °C) and DMEM-1% FBS
supplemented as above. Baby hamster kidney 21 (BHK21) cells were
grown at 37 °C in DMEM-10% FBS supplemented as above. BHK21
cells were used to grow virus stocks and to quantitate virus by
plaque assay.
Homology modeling
The full-length amino acid sequence of nsP3was runwith GENO3D
(http://geno3d-pbil.ibcp.fr). A macro domain protein Af1521 (Protein
Data Bank ID: 2bfq), which has an expectation value of 1.0e−32 when
compared with amino acid 3–158 of SINV nsP3, was chosen for a
template structure, and the structure of the nsP3 macro domain was
predicted by homology modeling.
Viruses, mutagenesis and sequencing
TE, a recombinant strain of SINV, was previously constructed by
replacing restriction fragments of the Toto1101 cDNA clone of SINV
with the E2 fragment from neuroadapted SINV and the E1 fragment
from the original SINV isolate AR339 (Lustig et al., 1988). At amino
acid positions 10 and 24 of nsP3, asparagines were changed to
alanines in the TE plasmid using the Quick Change® Site-Directed
Mutagenesis Kit (Stratagene) to create viruses with single mutations
(SM10 and SM24) and double mutations (DM). Viral RNAs were
transcribed using mMESSAGE mMACHINE® High Yield Capped RNA
Transcription Kit (Ambion) and then transfected into BHK21 cells
using Lipofectamine 2000 (Invitrogen). Virus titers were assessed by
plaque formation in BHK21 cells. For sequencing, viral RNAs were
puriﬁed fromvirus released into cell culturemedia using the QIAamp®
Viral RNAMini kit (Qiagen), or frommouse brains using RNease®Mini
Kit (Qiagen), and were ampliﬁed by RT-PCR using primers TE 3958
(+) (5′ GACCAGATTGTGTCTCAAGC 3′) and TE 4352(−) (5′ CAATTT-
CAAGGCTTCTGCTTC 3′). RT-PCR products were sequenced using the
primer TE 3958(+).
For analysis of replication, virus was diluted in DMEM-1% FBS, and
cells were infected at a multiplicity of infection (MOI) of 10 for 1 h at
31 °C (undifferentiated CSM14.1 cells), 39 °C (differentiated CSM14.1
cells), or 37 °C (BHK21 cells). Cells were then washed with medium 3
times, and the medium was replaced.
To assess viability, cells were washed with PBS, trypsinized,
resuspended, and incubated with 0.4% trypan blue. Unstained live
cells were counted, and cell viability was calculated by dividing the
number of live cells by the number of live cells at the time of infection.
Poly(ADP-ribose) (PAR) binding assay
The nsP3 macro domains from WT, SM10, SM24 and DM were
ampliﬁed by PCR and inserted into pRSET (Invitrogen) to express
hexahistidine (his)-tagged proteins. The macro domain proteins were
puriﬁed over a nickel column using ProBond™ Puriﬁcation System
(Invitrogen) andwere dot-blotted, along with lysozyme (Sigma), onto
a nitrocellulose membrane. The membrane was blocked for 1 h at RT
in TBS-T buffer (10 mM Tris, pH7.4, 150 mM NaCl, 0.04% Tween 20)
containing 5% nonfat dry milk and incubated with PAR (1 μg/ml,
Trevigen) in blocking buffer for 1 h at RT. The membrane was then
washed with TBS-T, blocked and incubated with antibody to PAR
(1:1000, Trevigen) overnight at 4 °C. Membrane was incubated with
HRP-conjugated secondary antibody (Amersham), and ECL (Amer-
sham) was used to visualize signals.
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Five day or 2 week-old CD-1 mice (Charles River Laboratories)
were infected intracerebrally with 1000 plaque forming units (PFU) of
virus in 10 μl phosphate-buffered saline (PBS) under isoﬂurane
anesthesia. To determine morbidity and mortality, groups of 10
infected animals were monitored daily and clinically scored. Survival
was plotted and compared using Kaplan–Meyer survival curves. To
assess virus replication, brains were collected and homogenized in
PBS using FastPrep® (MP Biomedicals), and assayed for PFU on BHK21
cells.
Analysis of viral RNA synthesis
To assess viral genomic and subgenomic RNA synthesis, differ-
entiated CSM14.1 cells were incubated with culture medium contain-
ing [5,6-3H] uridine (20 μCi/ml) (PerkinElmer) and dactinomycin
(1 μg/ml) (Calbiochem) at 39 °C for 2 h. Cells were then washed with
PBS and lysed with RNA STAT-60 (Tel-Test). RNAs were puriﬁed by
chloroform extraction and isopropanol precipitation, and were
separated at 120 volt-hours on a 1% agarose gel. For ﬂuorography,
the gel was ﬁxed with methanol at RT for 30 min, impregnated with
2.5% 2,5-diphenyloxazole in methanol overnight, and then washed
withwater. The gel was then driedwith a vacuumdryer at 50 °C for 1 h
and exposed to Kodak BioMax MS ﬁlm at −80 °C until signals were
detected.
To quantitate viral plus and minus strand RNA, SINV-infected
differentiated CSM14.1 cells were lysed, and total RNAs were puriﬁed
using the RNease® Mini Kit (Qiagen). Each cDNA was synthesized
from RNA using the Transcriptor First Strand cDNA Synthesis Kit
(Roche Applied Science) with a SINV-speciﬁc primer (SINV8456F 5′
CACGGCAATGTGTTTGCT 3′ for the cDNA synthesis of minus strand
RNA; SINV9899R 5′ AGCATTGGCCGACCTAACGCAGCAC 3′ for the cDNA
synthesis of plus strand RNA). Real time PCR was performed with the
synthesized cDNA, primers SVE2F 5′ TGGGACGAAGCGGACGATAA 3′
and SVE2R 5′ CTGCTCCGCTTTGGTCGTAT 3′, and Taqman probe 5′
[FAM] CGCATACAGACTTCCGCCCAGT [TAMRA] 3′ (Applied Biosys-
tems) using TaqMan™ PCR Core Reagent Kit (Applied Biosystems).
Real time PCR was run and analyzed with the 7500 Real Time PCR
System (Applied Biosystems).
Analysis of viral protein synthesis
For immunoblots, cells were lysed using radioimmune precipita-
tion assay (RIPA) buffer (1% Nonidet P-40, 0.1% sodium dodecyl sulfate
(SDS), 0.1% sodium deoxycholate, 10 mM Tris–Cl, 150 mM NaCl, 1 mM
EDTA, pH 7.5) containing a protease inhibitor cocktail (Sigma) and
Halt™ phosphatase inhibitor cocktail (Pierce). Cell lysates were
centrifuged at 13,000 rpm for 30 min to remove cell debris and used
for immunoblot. Antibodies used for immunoblotting were against
actin (Chemicon), nsP2 (polyclonal rabbit antibody raised against
amino acid 113–130 of nsP2, Quality Controlled Biochemicals (QCB)),
nsP3 (polyclonal rabbit antibody raised against amino acid 212–230 of
nsP3, QCB), and polyclonal rabbit antibody to SINV structural proteins
(Jackson et al., 1988).
To label newly synthesized proteins, differentiated CSM14.1 cells at
19 h post-infection or BHK21 cells at 6 h post-infectionwere incubated
with Met/Cys-free DMEM (MP Biomedicals) for 1 h, followed by
incubation with Met/Cys-free DMEM containing Tran35S (100 μCi/
ml) (MP Biomedicals) at 39 °C for 2 h (CSM14.1 cells) or 1 h (BHK21
cells). To chase labeled proteins, cells were washed, incubated with
cold media containing 15mg/l of L-Met, and lysed with RIPA buffer. To
inhibit proteasome activity, MG132 (1 μM, Biomol) was added to the
medium after infection. For immunoprecipitation, cell lysates were
incubated with antibody to nsP3, nsP2, or SINV structural proteins
(10 μg) in RIPA buffer overnight with gentle rocking at 4 °C.ImmunoPure® Immobilized Protein A/G (10 μl of settled gel) (Pierce)
was added to the mixture of cell lysate and antibody, followed by
overnight incubation with gentle rocking at 4 °C. The gel was washed
with RIPA buffer 3 times, and bound proteins were eluted by boiling at
90 °C with 2× SDS sample buffer for 5 min. Eluted proteins were
analyzed by PAGE. Then, the gel was ﬁxed in 50% methanol and 10%
glacial acetic acid (inwater) at RT for 30min, incubated in 10% glycerol
(inwater) for 5min to prevent cracking, dried using a vacuum dryer at
80 °C for 1 h, and exposed to Kodak BioMax MS ﬁlm at RT until signals
were detected.
Statistical analysis
Statistical analyses were performed using Student's unpaired t-test
or Kaplan–Meyer survival analysis and log rank test using GraphPad
QuickCalcs software.
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